Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes

Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes

(2015) Alireza Esteghamati et al.   Archives of Cardiovascular Diseases

Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway

(2015) Nagesha Guthalu Kondegowda et al.   Cell Metabolism

Osteoprotegerin is a Better Serum Biomarker of Coronary Artery Calcification than Osteocalcin in Type 2 Diabetes

(2015) Raelene Maser et al.   Endocrine Practice

Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease

(2015) Taichirou Morisawa et al.   International Heart Journal

Classical and alternative NF-κB signaling cooperate in regulating adipocyte differentiation and function

(2015) A Weidemann et al.   INTERNATIONAL JOURNAL OF OBESITY

Short-term effects of a combined nutraceutical of insulin-sensitivity, lipid level and indexes of liver steatosis: a double-blind, randomized, cross-over clinical trial

(2015) Arrigo FG Cicero et al.   Nutrition Journal

RANKL/OPG; Critical role in bone physiology

(2015) T. John Martin et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

2,3,7,8-Tetrachlorodibenzo-p-dioxin differentially suppresses angiogenic responses in human placental vein and artery endothelial cells

(2015) Yan Li et al.   TOXICOLOGY

Osteoprotegerin in Cardiometabolic Disorders

(2015) C. Pérez de Ciriza et al.   International Journal of Endocrinology

Mechanisms Linking Inflammation to Insulin Resistance

(2015) Li Chen et al.   International Journal of Endocrinology

Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION study

(2015) Yixin Niu et al.   BMC Endocrine Disorders

Osteoprotegerin in relation to insulin resistance and blood lipids in sub-Saharan African women with and without abdominal obesity

(2015) Clarisse Noël Ayina Ayina et al.   Diabetology & Metabolic Syndrome

Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (Review)

(2015) WEI LIU et al.   Molecular Medicine Reports

Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes

(2014) Melina B. Loureiro et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The Plasma Osteoprotegerin Level and Osteoprotegerin Expression in Renal Biopsy Tissue are Increased in Type 2 Diabetes with Nephropathy

(2014) S.-T Wang et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Changes of plasma concentration of osteoprotegerin and its association with endothelial dysfunction before and after hypouricemic therapy in patients with hyperuricemia

(2014) Hao-hua Wang et al.   Modern Rheumatology

Distinct roles of HIF1A in endothelial adaptations to physiological and ambient oxygen

(2014) Yi-Zhou Jiang et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes

(2014) Stella Bernardi et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Polymorphisms in genes in the RANKL/RANK/OPG pathway are associated with bone mineral density at different skeletal sites in post-menopausal women

(2014) P. Tu et al.   OSTEOPOROSIS INTERNATIONAL

OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice

(2014) M. Shimamura et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Transcriptional and Functional Adaptations of Human Endothelial Cells to Physiological Chronic Low Oxygen1

(2013) Yi-Zhou Jiang et al.   BIOLOGY OF REPRODUCTION

Enhanced Cellular Responses and Distinct Gene Profiles in Human Fetoplacental Artery Endothelial Cells under Chronic Low Oxygen1

(2013) Yi-Zhou Jiang et al.   BIOLOGY OF REPRODUCTION

Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus

(2013) Stefan Kiechl et al.   NATURE MEDICINE

Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor-κB Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus

(2013) Irene Lambrinoudaki et al.   International Journal of Endocrinology

Osteoprotegerin as a Marker of Atherosclerosis in Diabetic Patients

(2013) Areti Augoulea et al.   International Journal of Endocrinology

Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study

(2013) Pilar Gayoso-Diz et al.   BMC Endocrine Disorders

A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance

(2012) Eoin P. O'Sullivan et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Osteoprotegerin and Diabetes-Associated Pathologies

(2011) A. M. Blazquez-Medela et al.   CURRENT MOLECULAR MEDICINE

Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes

(2011) Alev E. Altinova et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: The implication of metabolic syndrome to detect insulin resistance

(2009) Alireza Esteghamati et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Relationships among serum receptor of nuclear factor-κB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineraldensity in postmenopausal women

(2009) Iraj Nabipour et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function

(2008) Joseph S. McGonigle et al.   ANGIOGENESIS

Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-α levels in men with type 2 diabetes

(2008) Subhashini Yaturu et al.   CYTOKINE

Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study

(2008) Marie-Hélène Gannagé-Yared et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY